drugset / Trial / NCT01178931
Dydrogesterone Versus Intravaginal Progesterone in the Luteal Phase Support
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare efficacy and tolerability of the dydrogesterone and the vaginal progesterone, used for luteal phase support. (Initial start date was January 2009 but not for patients' recruitment only for paper work, documents, team organization, statistical pre-work actions and to gain the official approval of Institutional Review Board. The recruitment started in October 2010 and continued until October 2013.)
Timeline
- Start
- 2010-10
- Primary completion
- 2013-10
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dydrogesterone | Other / unclassified | 10 mg | Oral |
| Comparator | Progesterone | Other / unclassified | 90 mg | Other |
Indications
No indication recorded.